No Prescription |
 |
 | ||
|
Diplene AF Cream Cormax |
|
| ||
No Prescription » Prescription Drugs 6 » Diplene AF Cream Cormax This medication is used to treat a variety of skin conditions (e.g. eczema dermatitis allergies rash). Clobetasol reduces the swelling itching and redness that can occur in these types of conditions. This medication is a very strong (super-high-potency) corticosteroid.How to use Clobetasol TopUse this medication on the skin only. Do not use it on the face groin or underarms unless directed to do so by your doctor.Wash and dry your hands before using. Clean and dry the affected area. Apply a thin film of medication to the affected area and gently rub in usually 2 times daily or as directed by your doctor. Do not bandage cover or wrap the area unless directed to do so by your doctor. If used in the diaper area on an infant do not use tight-fitting diapers or plastic pants.After applying the medication wash your hands unless you are using this medication to treat the hands. When applying this medication near the eyes avoid getting it in the eyes because this may worsen or cause glaucoma. Also avoid getting this medication in the nose or mouth. If you get the medication in these areas rinse with plenty of water. Buy Diplene AF Cream Cormax and other Prescription Drugs 6 products online at Medstore. Buy Online at Medstore - Click Here!
About Diplene AF Cream Cormax: Product Type: Prescription Drugs 6 Diplene AF Cream( Cormax Temovate Generic Clobetasol ) Diplene AF Cream (Cormax Temovate Generic Clobetasol) Cormax Temovate Generic Clobetasol 0.05% w/w 20gm 120gm(6 x 20gm) 60gm(3 x 20gm) Cormax Temovate Generic Clobetasol Diplene AF Cream
View more Prescription Drugs 6 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
